Improved endothelial dysfunction by cynanchum wilfordii in apolipoprotein E-/- mice fed a high fat/cholesterol diet

Journal of Medicinal Food

Volumn 15, Issue 2, 2012, Pages 169-179

  Choi, Deok Ho ^a   Lee, Yun Jung ^a,b   Oh, Hyun Cheol ^c   Cui, Ying Lan ^c   Kim, Jin Sook ^d   Kang, Dae Gill ^a,b   Lee, Ho Sub ^a,b  

^a Wonkwang University   (South Korea)

^b Wonkwang University   (South Korea)

^c Silla University   (South Korea)

^d Korea Institute of Oriental Medicine (KIOM)   (South Korea)

Author keywords

Cynanchum wilfordii; hyperlipidemia; hypertension; vascular inflammation; vasorelaxation

Indexed keywords

ACETYLCHOLINE; ANTILIPEMIC AGENT; APOLIPOPROTEIN; CYNANCHUM WILFORDII EXTRACT; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; ENDOTHELIN 1; FLUINDOSTATIN; GUANOSINE PHOSPHATE; HERBACEOUS AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERCELLULAR ADHESION MOLECULE 1; LOW DENSITY LIPOPROTEIN; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL DIET; CONTROLLED STUDY; CYNANCHUM; CYNANCHUM WILFORDII; DRUG STRUCTURE; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM; HYPERLIPIDEMIA; LIPID DIET; MALE; MEDICINAL PLANT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SYSTOLIC BLOOD PRESSURE; VASODILATATION;

ANIMALS; APOLIPOPROTEINS E; CHOLESTEROL; CYNANCHUM; DIET, HIGH-FAT; E-SELECTIN; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; HYPERLIPIDEMIAS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PLANT EXTRACTS; VASCULAR CELL ADHESION MOLECULE-1; VASODILATION;

CYNANCHUM WILFORDII; MUS; THEOBROMA CACAO;

EID: 84863078321     PISSN: 1096620X     EISSN: 15577600     Source Type: Journal    
DOI: 10.1089/jmf.2010.1222     Document Type: Article

References (42)

1. Haller H: Endothelial function: general considerations. Drugs 1997;53:1-10.
2. Spady DK, Woollett LA, Dietschy JM: Regulation of plasma LDL-cholesterol levels by dietary cholesterol and fatty acids. Annu Rev Nutr 1993;13:355-381. (Pubitemid 23227789)
3. Ito KM, Okayasu M, Koshimoto C, Shinohara A, Asada Y, Tsuchiya K, Sakamoto T, Ito K: Impairment of endothelium-dependent relaxation of aortas and pulmonary arteries from spontaneously hyperlipidemic mice (Apodemus sylvaticus). Vascul Pharmacol 2007;47:166-173. (Pubitemid 47095456)
4. Namikoshi T, Tomita N, Satoh M, Haruna Y, Kobayashi S, Komai N, Sasaki T, Kashihara N: Olmesartan ameliorates re-novascular injury and oxidative stress in Zucker obese rats enhanced by dietary protein. Am J Hypertens 2007;20:1085-1091. (Pubitemid 47446169)
5. Kubozono T, Koike A, Nagayama O, Tajima A, Aizawa T, Fu LT, Itoh H: High diastolic blood pressure during exercise is associated with hypercholesterolemia in patients with coronary artery disease. Int Heart J 2005;46:79-87.
6. Nishimatsu H, Suzuki E, Satonaka H, Takeda R, Omata M, Fujita T, Nagai R, Kitamura T, Hirata Y: Endothelial dysfunction and hypercontractility of vascular myocytes are ameliorated by flu-vastatin in obese Zucker rats. Am J Physiol Heart Circ Physiol 2005;288:1770-1776.
7. Babaei S, Picard P, Ravandi A, Monge JC, Lee TC, Cernacek P, Stewart DJ: Blockade of endothelin receptors markedly reduces atherosclerosis in LDL receptor deficient mice: role of endothelin in macrophage foam cell formation. Cardiovasc Res 2000;48: 158-167.
8. Li L, Chu Y, Fink GD, Engelhardt JF, Heistad DD, Chen AF: Endothelin-1 stimulates arterial VCAM-1 expression via NADPH oxidase-derived superoxide in mineralocorticoid hypertension. Hypertension 2003;42:997-1003. (Pubitemid 37413744)
9. Andreotti F, Porto I, Crea F, Maseri A: Inflammatory gene polymorphisms and ischaemic heart disease: review of population association studies. Heart 2002;87:107-112. (Pubitemid 34098367)
10. Blankenberg S, Barbaux S, Tiret L: Adhesion molecules and atherosclerosis. Atherosclerosis 2003;170:191-203. (Pubitemid 37377790)
11. Knowles JW, Maeda N: Genetic modifiers of atherosclerosis in mice. Arterioscler Thromb Vasc Biol 2000;20:2336-2345.
12. Zadelaar S, Kleemann R, Verschuren L, de Vries-Van der Weij J, van der Hoorn J, Princen HM, Kooistra T: Mouse models for atherosclerosis and pharmaceutical modifiers. Arterioscler Thromb Vasc Biol 2007;27:1706-1721. (Pubitemid 47207165)
13. Shan L, Liu RH, Shen YH, Zhang WD, Zhang C, Wu DZ, Min L, Su J, Xu XK: Gastroprotective effect of a traditional Chinese herbal drug "baishouwu" on experimental gastric lesions in rats. J Ethnopharmacol 2006;107:389-394. (Pubitemid 44344428)
14. Shin GH, Chio MG, Lee DW: Comparative study of the effects of various culture conditions on cell growth and gagaminine synthesis in suspension culture of Cynanchum wilfordii (Maxim.) Hemsley. Biol Pharm Bull 2003;26:1321-1325.
15. Niu JZ, Ye BK, Wang DF: Observation of the protection effect of Baishouwu to the liver of the high serum cholesterol mouse. Ji Sheng Chong Yu Yi Xue Kun Chong Xue Bao 1998;3:266-268.
16. 2, l-glutamate, and kainite. J Neurosci Res 2000;59:259-264. (Pubitemid 30036899)
17. Hwang BY, Kim SE, Kim YH, Kim HS, Hong YS, Ro JS, Lee KS, Lee JJ: Pregnane glycoside multidrug-resistance modulators from Cynanchum wilfordii. J Nat Prod 1999;62:640-643. (Pubitemid 29200757)
18. Li J, Kadota S, Kawata Y, Hattori M, Xu GJ, Namba T: Con-stitutents of the roots of Cynanchum bungei DECNE. Isolation and structures of four new glucosides, bungeiside-A,-B,-C, and-D. Chem Pharm Bull 1992;40:3133-3137. (Pubitemid 23049047)
19. Kang DG, Lee JK, Choi DH, Sohn EJ, Moon MK, Lee HS: Vascular relaxation by the methanol extract of Sorbus cortex via NO-cGMP pathway. Biol Pharm Bull 2005;28:860-864. (Pubitemid 40740656)
20. Pruneau D, Luccarini JM, Robert C, Bélichard P: Induction of kinin B1 receptor-dependent vasoconstriction following balloon catheter injury to the rabbit carotid artery. Br J Pharmacol 1994; 111:1029-1034.
21. Bentley MD, Rodriguez-Porcel M, Lerman A, Sarafov MH, Romero JC, Pelaez LI, Grande JP, Ritman EL, Lerman LO: Enhanced renal cortical vascularization in experimental hyper-cholesterolemia. Kidney Int 2002;61:1056-1063. (Pubitemid 34175475)
22. Whitman SC, Miller DB, Wolfe BM, Hegele RA, Huff MW: Uptake of type III hypertriglyceridemic VLDL by macrophages is enhanced by oxidation, especially after remnant formation. Arterioscler Thromb Vasc Biol 1997;17:1707-1715. (Pubitemid 27423991)
23. Gotto AM Jr: Low high-density lipoprotein cholesterol as a risk factor in coronary heart disease: a working group report. Circulation 2001;103:2213-2218. (Pubitemid 32458332)
24. Drexler H: Endothelial function in human coronary arteries in vivo. Focus on hypercholesterolemia. Hypertension 1991;18:I190-I199.
25. von Eckardstein A, Nofer JR, Assmann G: High density lipo-proteins and arteriosclerosis: role of cholesterol efflux and reverse cholesterol transport. Arterioscler Thromb Vasc Biol 2001; 21:13-27. (Pubitemid 32061923)
26. Nakashima Y, Plump AS, Raines EW, Breslow JL, Ross R: ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb 1994;14:133-140.
27. Scalia R, Gooszen ME, Jones SP, Hoffmeyer M, Rimmer DM 3rd, Trocha SD, Huang PL, Smith MB, Lefer AM, Lefer DJ: Simvastatin exerts both anti-inflammatory and cardioprotective effects in apolipoprotein E-deficient mice. Circulation 2001;103: 2598-2603. (Pubitemid 32521971)
28. Babaei S, Picard P, Ravandi A, Monge JC, Lee TC, Cernacek P, Stewart DJ: Blockade of endothelin receptors markedly reduces atherosclerosis in LDL receptor deficient mice: role of endothelin in macrophage foam cell formation. Cardiovasc Res 2000;48: 158-167.
29. Voelkel NF, Tuder RM: Hypoxia-induced pulmonary vascular remodeling: a model for what human disease? J Clin Invest 2000;106:733-738.
30. Endemann DH, Schiffrin EL: Nitric oxide, oxidative excess, and vascular complications of diabetes mellitus. Curr Hypertens Rep 2004;6:85-89. (Pubitemid 39359547)
31. Miike T, Kunishiro K, Kanda M, Azukizawa S, Kurahashi K, Shirahase H: Impairment of endothelium-dependent ACh-in-duced relaxation in aorta of diabetic db/db mice-possible dysfunction of receptor and/or receptor-G protein coupling. Naunyn Schmiedebergs Arch Pharmacol 2008;377:401-410.
32. Takase H, Moreau P, Küng CF, Nava E, Lüscher TF: Anti-hypertensive therapy prevents endothelial dysfunction in chronic nitric oxide deficiency. Effect of verapamil and trandolapril. Hypertension 1996;27:25-31. (Pubitemid 26017676)
33. Gervais M, Pons S, Nicoletti A, Cosson C, Giudicelli JF, Richer C: Fluvastatin prevents renal dysfunction and vascular NO deficit in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2003;23:183-189. (Pubitemid 36231926)
34. Fulton D, Harris MB, Kemp BE, Venema RC, Marrero MB, Stepp DW: Insulin resistance does not diminish eNOS expression, phosphorylation, or binding to HSP-90. Am J Physiol Heart Circ Physiol 2004;287:H2384-H2393. (Pubitemid 39557106)
35. Hsueh WA, Law RE: Insulin signaling in the arterial wall. Am J Cardiol 1999;84:21J-24J. (Pubitemid 29334856)
36. Nigro J, Osman N, Dart AM, Little PJ: Insulin resistance and atherosclerosis. Endocr Rev 2006;27:242-259.
37. Aiello VD, Gutierrez PS, Chaves MJ, Lopes AA, Higuchi ML, Ramires JA: Morphology of the internal elastic lamina in arteries from pulmonary hypertensive patients: a confocal laser microscopy study. Mod Pathol 2003;16:411-416. (Pubitemid 36618460)
38. Rohani M, Jogestrand T, Ekberg M, van der Linden J, Källner G, Jussila R, Agewall S: Interrelation between the extent of atherosclerosis in the thoracic aorta, carotid intima-media thickness and the extent of coronary artery disease. Atherosclerosis 2005;179:311-316. (Pubitemid 40364625)
39. Diep QN, Amiri F, Touyz RM, Cohn JS, Endemann D, Neves MF, Schiffrin EL: PPARalpha activator effects on Ang II-induced vascular oxidative stress and inflammation. Hypertension 2002;40:866-871. (Pubitemid 35434908)
40. Coxon A, Tang T, Mayadas TN: Cytokine-activated endothelial cells delay neutrophil apoptosis in vitro and in vivo. A role for granulocyte/macrophage colony-stimulating factor. J Exp Med 1999;190:923-934.
41. Sasakawa T, Sasakawa Y, Masunaga T, Fujitsu T, Hirayama Y, Ohkubo Y, Mutoh S: FK506 suppresses E-selectin, ICAM-1 and VCAM-1 expression on vascular endothelial cells by inhibiting tumor necrosis factor alpha secretion from peripheral blood mononuclear cells. Cytokine 2005;29:67-71. (Pubitemid 39626638)
42. Lee YJ, Choi DH, Kim EJ, Kim HY, Kwon TO, Kang DG, Lee HS: Hypotensive, hypolipidemic, and vascular protective effects of Morus alba L. in rats fed an atherogenic diet. Am J Chin Med 2011;39:39-52.